RxDoctor Payments Data

Laura Black, PA

Physician Assistant · Gonzales, LANPI 1760748131

Payments from drug & device makers

$3,325in general payments, 2019–2025

Across 224 payments — averaging $14.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$924
  • GSK$882
  • Astellas Pharma US Inc$188
  • Abbott$151
  • Johnson & Johnson$118
  • Travere Therapeutics, Inc.$103
  • plus $960 from 26 others

What the payments were for

  • Food & beverage$3,325100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,325 in reported general payments places this provider in the 85th percentile of 1,246 physician assistant providers in Louisiana.

See all physician assistant providers in Louisiana

Medicare billing

Part B allowed, 2024
$25,619
Medicare patients
61
Services billed
425

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide98$117,916
MounjaroTirzepatide92$109,426
JardianceEmpagliflozin47$73,523
Trelegy ElliptaFluticasone/Umeclidin/Vilanter79$61,984
EliquisApixaban16$17,647
Stiolto RespimatTiotropium Br/Olodaterol Hcl31$14,278
LinzessLinaclotide16$13,498
Synjardy XrEmpagliflozin/Metformin Hcl17$13,048
NexlizetBempedoic Acid/Ezetimibe17$12,778
XareltoRivaroxaban13$10,909
Breo ElliptaFluticasone/Vilanterol15$10,736
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog13$8,560
GlyxambiEmpagliflozin/Linagliptin13$7,973
MovantikNaloxegol Oxalate12$4,692
Omeprazole168$2,129

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$89$117,91698 claims
Lilly USA, LLCMounjaro$77$109,42692 claims
Boehringer IngelheimJardiance, Stiolto Respimat, Synjardy Xr, Glyxambi$13$108,822108 claims
GSKTrelegy Ellipta, Breo Ellipta$882$72,72094 claims
PfizerEliquis$101$17,64716 claims
AbbVieLinzess$924$13,49816 claims
Esperion Therapeutics, Inc.Nexlizet$20$12,77817 claims
Johnson & JohnsonXarelto$118$10,90913 claims
Almatica Pharma LLCSertraline Hcl$38$537107 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,246 physician assistant providers in Louisiana.

Other physician assistant in Gonzales

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →